Role of Big Tech in Society

Debate between Bell Ribeiro-Addy and Mark Pritchard

Tuesday 23rd June 2026 Westminster Hall

[Mark Pritchard]

The hon. Gentleman makes an excellent point, and will touch on sovereignty later. The European Union—it is a positive in many ways—is looking at that. That is partly why I am making this speech today; it is about sovereignty too.

Who knows the most—who owns or hosts the most data—and how that data is used determines who has the hierarchical advantage. I would argue that that gives the democratic or control advantage, not just the commercial advantage. The people, through democratically elected government, should always have ultimate control.

[Bell Ribeiro-Addy (Clapham and Brixton Hill) (Lab)]

I congratulate the right hon. Gentleman on securing this very important debate. Many big tech companies are a cause of concern, but a particular one is Palantir, which holds Government contracts worth more than £900 million, spanning 10 Departments. Does he agree that more concerning than its dominance is the fact that we do not know what data it holds and has access to? Numerous groups warn that patient data in the NHS federated data platform could be accessible by US authorities under the American CLOUD—Clarifying Lawful Overseas Use of Data—Act, so does he agree that the Government must exercise the February 2027 break clause until those questions are property and publicly answered?

[Mark Pritchard]

The hon. Lady makes an important point. I will not name individual companies today—she has clearly put her views on the record—but no monopoly, be it a public or private sector monopoly, is good for our constituents, consumers and small and medium-sized businesses. She makes her case well.

Will this universal knowledge that tech companies have—this data capture—always be used for good? Will it always be benign? Will it seek the common good or the corporate good?

--- Later in debate ---

[Bell Ribeiro-Addy (Clapham and Brixton Hill) (Lab)]

I thank the right hon. Member for The Wrekin (Mark Pritchard) for bringing forward this important debate. It comes at a pertinent time, as we discuss the impact of social media on our children, the way we use AI, and the influence of big tech companies, including on our lives.

As I pointed out earlier, a growing number of voices—doctors, nurses, civil society organisations and Members across this House—are sounding the alarm about the unchecked expansion of one company: Palantir Technologies. The concern seems to centre around two issues. The first is the sheer scale of Palantir’s involvement in our public infrastructure. It holds at least 34 current and past Government contracts across at least 10 Departments, totalling a minimum of £900 million. The true figure is likely higher, since several contracts remain unacknowledged or heavily redacted. Palantir’s largest single contract is the NHS federated data platform, which is worth £330 million over seven years. My inbox has been rammed with constituents calling for the Government to trigger Palantir’s February 2027 break clause. I support that call, and I hope the Minister will say whether the Government do, too.

[Mark Pritchard]

It is unusual for me to intervene, but I am glad the hon. Lady mentioned that number. I had no idea it was that many contracts for that particular company, and that underscores some of the points I was making. I can think of certain service companies, which I will not mention today, that have multiple contracts, some of which they deliver well, and some of which have been a complete disaster under successive Governments. I can think of some global IT companies—not big tech, but the old, traditional hardware companies—where some of those programmes are delivered well, and some have been a complete disaster. To have so many contracts in the hands of so few is concerning.

[Bell Ribeiro-Addy]

That is why I was so pleased the right hon. Member called the debate. I hope he agrees that once a contractor has failed for one Department, it should not be given a contract for another Department. I hope the Minister will speak to that.

I hugely support my constituents’ call for the Government to use that February 2027 break clause with Palantir. I hope the Minister will tell us more about whether they intend to act on that. Some will say that Palantir’s expanding portfolio simply proves that it is the best company for the job. That may be true for some places—I doubt it—but it is not a reason to dismiss concerns. We should be worried about one company having this much dominance across so many pillars of our society, and particularly a foreign corporation that may not have the UK’s best interests at heart. I say that with confidence, because Palantir’s founder, Peter Thiel, has accused us of having Stockholm syndrome over our affection for the NHS and said that we need to

“rip the whole thing from the ground and start over”.

His broader political views are just as concerning, and I encourage Members to look into them.

The current CEO of Palantir UK is Oswald Mosley’s grandson. I do not wish to judge a man solely by his grandfather’s sins, but that gets harder when the views on display are not entirely dissimilar. Nor can we ignore Peter Mandelson’s role in arranging the Prime Minister’s undeclared 2025 visit to Palantir’s headquarters—a meeting where no minutes were taken and that raised transparency questions that are still unanswered.

The second concern is data. Palantir built its reputation as a surveillance and intelligence tool for the US military; it is not a healthcare company, but a data aggregation company with software designed to link datasets across systems. This is no longer a hypothetical risk: NHS England has confirmed that Palantir staff can access identifiable patient data on the federated data platform through a new admin role on the national data integration tenant. The British Medical Association, Medacs, the Good Law Project, Privacy International and Amnesty International have all warned that that data could become accessible to other departments, or to US authorities under the American Clarifying Lawful Overseas Use of Data Act 2018, regardless of what any contract says.

Some 50,000 patients have written to their NHS trust boards to urge them not to adopt the platform. I am not suggesting that every Palantir contract should be cancelled tomorrow, but we are sleepwalking into a dependency on this company that we will come to deeply regret.